会上，先进计算与关键软件（信创）海河实验室发布了眼科智疗产品，该产品以信创智能算力核为核心，融合了智能模型设计与安全可信计算等技术，赋能 眼科等健康医疗多场景应用。同时，河西区投促局与汇智星源、华鲲振宇共同发布了"招商大模型一体机"，将为产业招商和企业服务提供智能化支撑。河西 区数据局与深圳数联天下智能科技有限公司签订意向合作协议，双方将整合各自优质资源，长期高效实现共同发展。 本次大会的成功举办，为信创产业与健康医疗领域的融合发展搭建了良好的交流与合作平台。通过政、产、学、研、医各方的共同努力，将有效打通数据脉 络、筑牢安全底座、激活创新应用，构建基于信创体系的"人工智能+"健康医疗创新方案，推动健康医疗产业高质量发展。 党的二十届四中全会对推动科技创新和产业创新深度融合、优化提升传统产业、培育壮大新兴产业和未来产业等作出重要部署。锚定目标，河西区以推动高 质量发展为主题，以发展新质生产力为重点，以推动科技创新和产业创新深度融合为路径，继续发挥信创产业集聚优势和健康医疗企业资源优势，加大技术 研发和人才培养力度，推动信创与健康医疗的深度融合，以新质生产力塑造新动能，为经济行稳致远提供坚实支撑。（李揽月/摄） ...

Core Viewpoint - Southbound funds reduced their holdings in Health Road (02587.HK) by 1.6675 million shares on November 21, 2025, indicating a trend of net selling over the past 20 trading days [1] Group 1: Southbound Fund Activity - In the last 5 trading days, there were 2 days of net buying by southbound funds, totaling an increase of 1.7312 million shares [1] - Over the past 20 trading days, southbound funds have reduced their holdings on 13 days, with a total net reduction of 11.4343 million shares [1] - As of now, southbound funds hold 18.6 million shares of Health Road, accounting for 21.13% of the company's total issued ordinary shares [1] Group 2: Shareholding Changes - On November 21, 2025, the total number of shares held was 186 million, reflecting a decrease of 166.75 thousand shares, or a change of -0.89% [2] - On November 20, 2025, the total number of shares held was 187 million, with a decrease of 135.55 thousand shares, or -0.72% [2] - On November 19, 2025, the total number of shares held was 189 million, with an increase of 94.15 thousand shares, or +0.50% [2] - On November 18, 2025, the total number of shares held was 188 million, with an increase of 520.70 thousand shares, or +2.85% [2] - On November 17, 2025, the total number of shares held was 182 million, reflecting a decrease of 139.43 thousand shares, or -0.76% [2] Group 3: Company Overview - Health Road Holdings Limited primarily engages in providing enterprise services, digital marketing services, and health care services [2] - The company operates through three segments: enterprise services and digital marketing services, health care services, and other health services and products [2] - The enterprise services and digital marketing services segment includes content services, information technology services, and digital marketing services [2] - The health care services segment provides medical support services and value-based medical services [2] - The company mainly conducts its business in the domestic market [2]

Core Insights - The eighth China International Import Expo (CIIE) concluded on November 10, showcasing Omron Group's commitment to "New Quality Era Automation+" with a focus on industrial automation, components, and healthcare solutions [1][2] - Omron emphasizes that the CIIE serves as a platform for global enterprises to collaboratively shape a sustainable future, responding to China's industrial upgrade and social development needs through technological innovation [1][5] Industry Collaboration - Omron has witnessed the growth and value of the CIIE, viewing it as a high ground for advanced technology exchange and collaboration, allowing for in-depth discussions on automation, AI, and health management [2][5] - The establishment of a "Joint Innovation Laboratory" with the Yangtze River Delta National Technology Innovation Center highlights Omron's commitment to leveraging regional innovation resources for collaborative research and talent development [5][10] Automation and Digital Transformation - Omron's core business in industrial automation is showcased through its "i-Automation!" concept, integrating sensing, control, and AI technologies to meet the demands of the new quality era [5][7] - Innovative solutions presented include a workpiece traceability system capable of high-speed production quality tracking and an automatic vibration suppression system for mixed-flow production [7][10] Healthcare Innovation - The shift in consumer health management from "passive treatment" to "active management" is addressed by Omron's innovative healthcare products, including smart blood pressure monitors and continuous glucose monitoring systems [8][9] - Omron aims to create a proactive health management ecosystem, enhancing health services through community engagement and environmental initiatives [9][10] Sustainability and Carbon Neutrality - Omron's long-term strategy, "Shaping the Future 2030," emphasizes sustainable development, with a goal to reduce greenhouse gas emissions by 65% by 2030 and achieve net-zero emissions by 2050 [10][11] - The introduction of energy-efficient products and services supports clients in achieving carbon neutrality and enhancing supply chain sustainability [11][12] Future Development Strategy - Omron plans to deepen its localization strategy in China over the next three to five years, focusing on digitalization, green manufacturing, and local innovation [12] - The company aims to leverage its technological expertise to empower the industry ecosystem, contributing to high-quality economic development in China [12]

Core Viewpoint - The China International Import Expo (CIIE) serves as a strategic platform for companies to connect deeply with the Chinese market and co-create value with partners, emphasizing the importance of ecological cooperation and long-term commitment to the market [1][3]. Group 1: Company Perspective - Omron views its participation in CIIE as a crucial opportunity to establish deep connections with the Chinese market, having participated for eight consecutive years [1][3]. - The company recognizes the long-term development potential of the Chinese market, noting that CIIE has evolved from a product showcase to a high-level open platform for industry ecosystem co-construction [3][4]. - Omron has showcased advanced technologies and applications in three core business areas: industrial automation, healthcare, and component solutions over the past seven expos [3][4]. Group 2: Industry Trends - CIIE focuses on the integration of exhibits with supply chains and emphasizes cutting-edge fields such as smart manufacturing, artificial intelligence, and renewable energy [3][4]. - The expo creates rich scenarios for industrial collaborative innovation, allowing companies to engage in deep discussions on automation, AI, and health management [4][5]. - Omron's collaboration with local internet companies aims to drive innovation in the health product sector, enhancing service efficiency and quality in the healthcare industry [4][5]. Group 3: Future Outlook - Omron signed a cooperation framework agreement with the Yangtze River Delta National Technology Innovation Center to explore collaborative development paths in joint research, talent cultivation, and results transformation [5]. - The company plans to continue its localization strategy guided by its "Shaping the Future 2030" long-term strategy, focusing on achieving a digital society, carbon neutrality, and extending healthy lifespans [5]. - Omron expresses confidence in its development in China, citing an increasingly open and vibrant business environment, enhanced intellectual property protection, and improved business convenience [5].

中国经济网上海11月6日讯(记者杨秀峰)第八届中国国际进口博览会(简称"进博会")于11月5日-10日在上海举行。 "我们将进博会视为与中国市场深度连接、与各方伙伴价值共创的战略平台。参展的核心诉求不仅是展示技术，更是通过这一开放窗口深化生态合作、践行 对中国市场的长期承诺。"欧姆龙株式会社执行董事、欧姆龙(中国)有限公司董事兼总经理徐坚表示，作为连续八年参展的"全勤生"，欧姆龙视其为与中国市 场建立深层联系的重要节点，并通过进博会平台，持续引进全球领先的创新技术和解决方案，积极融入本地产业生态，开拓合作渠道。 徐坚表示，欧姆龙最初参与进博会，源于对中国市场长期发展潜力的认可。八年来，企业切身感受到进博会的功能已从商品展示逐步升级为行业生态共建平 台，更加注重展品与产业链、供应链的深度融合，并聚焦智能制造、人工智能、新能源等前沿领域。 徐坚介绍，过去七届进博会，欧姆龙全面展示了在工业自动化、健康医疗、器件与模块解决方案三大核心业务领域的前沿技术和应用成果，与众多本土合作 伙伴共建、共享、共成长。今年第八次参展，欧姆龙希望进一步深化各方合作，紧密对接中国在数字化、双碳目标、健康中国等领域的战略方向，持续贡献 企 ...

Core Viewpoint - Southbound funds have reduced their holdings in Health Road (02587.HK) by 203.15 million shares on November 4, with a total net reduction of 345.0 million shares over the last five trading days and 891.4 million shares over the last twenty trading days [1][2]. Group 1: Shareholding Changes - As of November 4, 2025, southbound funds hold 190 million shares of Health Road, accounting for 21.63% of the company's total issued ordinary shares [1]. - The shareholding changes over the last five trading days include a reduction of 203.15 million shares on November 4, a reduction of 142.35 million shares on November 3, an increase of 73.30 million shares on October 31, a reduction of 110.10 million shares on October 30, and an increase of 37.30 million shares on October 28 [2]. Group 2: Company Overview - Health Road Holdings Limited is primarily engaged in providing enterprise services, digital marketing services, and health care services as an investment holding company [2]. - The company operates through three main segments: enterprise services and digital marketing services, health care services, and other health services and products sold through various online and offline channels [2].

Group 1 - The core point of the news is that southbound funds have reduced their holdings in Health Road (02587.HK) by 226.15 million shares on October 27, with a total net reduction of 359.9 million shares over the past five trading days and 763.8 million shares over the past twenty trading days [1][2] - As of now, southbound funds hold 193 million shares of Health Road, accounting for 22.03% of the company's total issued ordinary shares [1][2] - The company operates primarily in three segments: enterprise services and digital marketing services, health care services, and other health services and products [2] Group 2 - The enterprise services and digital marketing services segment includes content services, information technology services, and digital marketing services [2] - The health care services segment provides medical support services and value-based medical services [2] - The other segment offers various health services and products through online and offline channels, such as patient visitation services and nutritional supplements sales [2]

Core Viewpoint - The era of land finance is officially over, and the next five years will see a shift in wealth towards technology and green innovation, with a target to increase per capita GDP from $13,000 to $20,000 by 2035 [1][3] Group 1: Economic Transition - The focus of economic growth has shifted from investment and real estate to high-quality development, emphasizing self-controlled industrial chains, particularly in chips and artificial intelligence [3][5] - Significant investments are expected in high-end manufacturing, aerospace, and comprehensive transportation networks, indicating a strong capital flow into these sectors [5] Group 2: Emerging Opportunities - The AI sector is moving from concept to practical integration across various industries, while quantum technology is being pushed from laboratories to applications [5] - The domestic market is identified as a new growth area, with sectors like specialty dining, healthcare, and cultural entertainment poised for rapid development, especially in central and rural regions [5][6] Group 3: Policy Support and Market Trends - The "Three Guarantees" policy aims to support employment, consumption, and livelihood, benefiting businesses related to basic living needs, such as community services and affordable consumption [6] - The silver economy is projected to reach ¥30 trillion by 2035, creating a vast industry around elderly care and related services [8] Group 4: Infrastructure and Digital Trade - Urban development will shift from expansion to internal renewal, with over 700,000 kilometers of underground pipeline renovations expected, generating nearly ¥5 trillion in new investment demand [6] - The digital trade sector is expanding, with a current scale exceeding ¥3 trillion and 165 cross-border e-commerce pilot zones, allowing even small companies to engage in global trade [6] Group 5: Regional Development and Financial Market - Key regional developments are focused on the Yangtze River Delta and the Guangdong-Hong Kong-Macao Greater Bay Area, with specific attention to integrated circuits and biomedicine [10] - Financial market reforms are optimizing channels for long-term funds, enhancing market stability and potentially increasing foreign investment in A-shares [10]

Core Insights - The Silkway Beijing 2025 Sino-Finnish Youth Innovation Industry Matching Event was held on October 24, marking the conclusion of the first Silkway Sino-Finnish Startup Accelerator Program in Beijing [1] - The Aalto Innovation Association, a key part of Finland's innovation ecosystem, has launched over 20 innovation activities and platforms, incubating more than 600 companies with a total market value exceeding €18 billion [1] - The event focused on collaboration potential in emerging technology fields such as robotics, healthcare, and aerospace, showcasing Finnish startups like Fleetview and Corle [1] Group 1 - The Aalto Innovation Association is supported by Aalto University, the City of Espoo, and the Finnish Innovation Fund, making it the largest university-based innovation organization in Europe [1] - The Silkway initiative aims to accelerate startups and tech talent specifically in the Chinese market [1] - The event gathered government departments, startups, chambers of commerce, and related institutions from both China and Finland [1] Group 2 - Finnish Ambassador to China, Li Yanna, emphasized the shared vision between China and Finland in technology and innovation, highlighting the importance of collaboration among students, entrepreneurs, and innovators [2] - The Aalto Innovation Association's InnoHub (Beijing) innovation base was inaugurated at the event, located in the Zhongguancun North Latitude AI Community [2] - A joint innovation plan for robotics between China and Finland was announced, which will include regular innovation competitions and technical workshops in Beijing and Helsinki [2]

Core Viewpoint - Dahu Co., Ltd. is changing its name to "Dahu Health Industry Co., Ltd." to better reflect its strategic focus on health products and healthcare, moving away from its traditional aquaculture identity [1][2] Group 1: Company Name Change - The name change aims to clearly convey the company's strategy of integrating health products and healthcare services, breaking the market's perception of it as a traditional aquaculture enterprise [1] - The full name will change from "Dahu Aquaculture Co., Ltd." to "Dahu Health Industry Co., Ltd." while the stock abbreviation "Dahu Co., Ltd." will remain unchanged [1] Group 2: Business Structure and Revenue - Traditional aquaculture operations now contribute less than 10% to the company's revenue, while medical, seafood processing, and liquor businesses account for over 90% [2] - The company has established a dual-driven model in the health industry, combining health products and healthcare services [3] Group 3: Health Products and Medical Services - In the health products sector, Dahu Co. is upgrading its traditional business with organic seafood and ready-to-eat products, achieving over 100 million yuan in annual sales for its crayfish series [3] - The company entered the healthcare sector by acquiring Dongfang Huakang Medical Management Co., Ltd., contributing approximately 216 million yuan in profits since the acquisition [3] Group 4: Technological Integration - The company has added new services related to artificial intelligence in its business scope, including AI application system integration and technology consulting [3] - A new subsidiary, Shanghai Kuai Zhi Medical Technology Co., Ltd., has been established to focus on smart hospital information systems and related technologies [3][4] Group 5: Strategic Direction - Dahu Co. aims to explore upstream and downstream medical services while seeking strategic partnerships in intelligent applications to enhance the integration of technology and health services [4] - The company is focused on improving the efficiency and quality of healthcare services through technological empowerment, aiming for a transformation from "fisherman" to "educator" in value creation [4]